Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Artra GroupTSE:6029 -1.04%50 Return-on-Tangible-Asset is 8.19% as of Dec. 2025, which is 1180% above its 10-year median of 0.64. GuruFocus rates TSE:6029 with a GF Score™ of 50/100 and a GF Value™ of 円139.64 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 680 Healthcare Providers & Services companies, Artra Group ranks better than 58.53% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Artra Group's annualizedNet Income for the quarter that ended in Dec. 2025 was 円318 Mil. Artra Group's average total tangible assets for the quarter that ended in Dec. 2025 was 円3,876 Mil. Therefore, Artra Group's annualized Return-on-Tangible-Asset for the quarter that ended in Dec. 2025 was 8.19%.
The historical rank and industry rank for Artra Group's Return-on-Tangible-Asset or its related term are showing as below:
TSE:6029'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -10.97 Med: 0.64 Max: 10.14
Current: 4.46
During the past 13 years, Artra Group's highest Return-on-Tangible-Asset was 10.14%. The lowest was -10.97%. And the median was 0.64%.
TSE:6029's Return-on-Tangible-Asset is ranked better than 58.53% of 680
companies
in the Healthcare Providers & Services industry
Industry Median: 2.66
vs TSE:6029: 4.46
Artra Group (TSE:6029) Return-on-Tangible-Asset Explanation
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Artra Group Return-on-Tangible-Asset Related Terms
Artra Group Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for Artra Group's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:6029 vs HCA, THC, DVA: Return-on-Tangible-Asset Comparison
For the Medical Care Facilities subindustry, Artra Group's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Artra Group Return-on-Tangible-Asset vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Artra Group's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Artra Group's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Dec. 2025) net income data.
What does a Return-on-Tangible-Asset of 8.19% mean?
Artra Group (TSE:6029) has a Return-on-Tangible-Asset of 8.19% as of Dec. 2025. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Artra Group and its competitors. This is 1180% above median its historical median of 0.64. According to the industry distribution chart, Artra Group ranks #282 out of 680 companies in the Healthcare Providers & Services industry, placing it in the top 41.5%.
Is Artra Group's Return-on-Tangible-Asset too high?
Artra Group's current Return-on-Tangible-Asset of 8.19% is 1180% above median its 10-year median of 0.64. The Healthcare Providers & Services industry median Return-on-Tangible-Asset is 2.66. Artra Group's value of 8.19% is 207.9% above this industry median. Based on the distribution chart, Artra Group ranks #282 out of 680 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Artra Group has a GF Score™ of 50/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Artra Group's Return-on-Tangible-Asset compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Artra Group ranks #282 out of 680 companies for Return-on-Tangible-Asset. This puts Artra Group in the upper half of its industry. The industry median Return-on-Tangible-Asset is 2.66. Artra Group's value of 8.19% is 207.9% above this benchmark. While the company's 10-year median is 0.64 vs. the industry median of 2.66, Artra Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Healthcare Providers & Services company?
The median Return-on-Tangible-Asset among Healthcare Providers & Services companies is 2.66, based on 680 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Artra Group's current Return-on-Tangible-Asset of 8.19% is 207.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Artra Group and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Asset is 2.66 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Artra Group's current Return-on-Tangible-Asset is 8.19%, which is 1180% above median its own 10-year median of 0.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Artra Group stock overvalued right now?
Based on GuruFocus' analysis, Artra Group (TSE:6029) is currently considered Significantly Overvalued. The stock's GF Value™ is 円139.64, compared to a current price of 円191.00 — trading 36.8% above its estimated fair value. The current Return-on-Tangible-Asset is 8.19%, which is 1180% above median its 10-year median of 0.64 and 207.9% above the Healthcare Providers & Services industry median of 2.66. Artra Group's overall GF Score™ is 50/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Artra Group (TSE:6029), the current Return-on-Tangible-Asset is 8.19% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Artra Group (TSE:6029) Overvalued in 2026?
Based on GuruFocus' analysis, Artra Group stock appears to be overvalued.
The current stock price of 円191.00 is trading 36.8% above its estimated GF Value™ of 円139.64.
GuruFocus considers Artra Group to be Significantly Overvalued.
Key valuation signals for TSE:6029:
Return-on-Tangible-Asset: 8.19% (1180% above median its 10-year median of 0.64)
GF Value™: 円139.64 vs. price of 円191.00 (36.8% above fair value)
Industry Position: 207.9% above the Healthcare Providers & Services median (#282 of 680)
No single metric tells the full story. See the TSE:6029 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Artra Group Corp is engaged in the healthcare support business, providing services that assist the operation and management of clinics and related facilities. The group has two reportable segments: Acupuncture & Orthopedic Clinic Support and Toy Sales Business. The Acupuncture and Orthopedic Clinic Support segment is involved in supporting acupuncture and orthopedic clinics through services such as bone setting chains, provision of equipment and consumables, Attra billing services, HONEY-STYLE, and nursing care support. The Toy Sales segment focuses on the sale of toys, stationery, and other related products.
50GF Score
Get the complete analysis for TSE:6029
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:6029 has been successfully added to your 
